Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Bitter orange (Citrus aurantium) is sometimes used as a supplement ingredient to support metabolic syndrome, largely due to the presence of the protoalkaloid p-synephrine, which is structurally similar to ephedrine. Some small-scale clinical trials and animal studies have investigated its effects on weight loss, lipid metabolism, and glucose regulation—key components of metabolic syndrome. The proposed mechanisms of action include increased thermogenesis, appetite suppression, and mild stimulation of beta-adrenergic receptors, which may enhance fat oxidation and energy expenditure.

However, the scientific evidence supporting the use of bitter orange for metabolic syndrome is limited and of low quality. Most clinical studies focus on its use for weight loss, with inconsistent results and often in combination with other ingredients, making it difficult to attribute effects solely to bitter orange. Evidence for its impact on cholesterol, blood pressure, or insulin sensitivity is scarce and inconclusive. There are also safety concerns, as bitter orange has been associated with increased heart rate and blood pressure in some users, raising the risk of cardiovascular events, particularly when combined with other stimulants.

In summary, while there is some scientific rationale and preliminary evidence for the use of bitter orange in addressing aspects of metabolic syndrome, robust, high-quality clinical data are lacking. Its use is not widely endorsed by medical authorities for this purpose, and safety concerns further limit its recommendation.

More about Bitter orange
More about Metabolic Syndrome

Other ingredients used for Metabolic Syndrome

Other health conditions supported by Bitter orange

Products containing Bitter orange